Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.33

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: poodle who wrote (830)	3/15/2000 6:30:00 PM
From: david james	Read Replies (1) of 52153

Cell Genesys (CEGE) now valued at around negative 8 million. You buy the stock which almost equals the cash position and the position in ABGX, and you get the company for free - one with a very promising cancer vaccine and with patents that should produce enough revenues to make the company profitable in 2000 (according to the CEO). streetadvisor.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next